Juan Antonio
Berto Botella
Colaborador Médico
Pablo Antonio
Sánchez Salcedo
Investigador fins a 2022
Publicacions en què col·labora amb Pablo Antonio Sánchez Salcedo (10)
2019
-
Emphysema phenotypes and lung cancer risk
PLoS ONE, Vol. 14, Núm. 7
2017
-
Clinical Features of Smokers With Radiological Emphysema But Without Airway Limitation
Chest, Vol. 151, Núm. 2, pp. 358-365
-
Telomere length, COPD and emphysema as risk factors for lung cancer
European Respiratory Journal
2016
-
Is COPD a progressive disease? A long term BODE cohort observation
PLoS ONE, Vol. 11, Núm. 4
-
The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development
Lung Cancer, Vol. 97, pp. 28-34
2015
-
COPD comorbidities network
European Respiratory Journal, Vol. 46, Núm. 3, pp. 640-650
-
Improving selection criteria for lung cancer screening: The potential role of emphysema
American Journal of Respiratory and Critical Care Medicine, Vol. 191, Núm. 8, pp. 924-931
-
Lung Cancer Screening: Fourteen Year Experience of the Pamplona Early Detection Program (P-IELCAP)
Archivos de Bronconeumologia, Vol. 51, Núm. 4, pp. 169-176
-
Lung cancer in patients with chronic obstructive pulmonary disease: Development and validation of the COPD lung cancer screening score
American Journal of Respiratory and Critical Care Medicine, Vol. 191, Núm. 3, pp. 285-291
2014
-
Prognostic evaluation of copd patients: Gold 2011 versus bode and the copd comorbidity index cote
Thorax, Vol. 69, Núm. 9, pp. 799-804